Sign Up to like & get
recommendations!
0
Published in 2018 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2017.11.031
Abstract: Small-molecule agonists for the Toll-like receptors (TLR) 7 and 8 are effective for the immunotherapy of skin cancer when used as topical agents. Their systemic use has however been largely unsuccessful due to dose-limiting toxicity.…
read more here.
Keywords:
nanoparticles loaded;
based nanoparticles;
mpeg pla;
tlr7 ligand ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Bioconjugate chemistry"
DOI: 10.1021/acs.bioconjchem.9b00560
Abstract: Adjuvants enhance the immune response during vaccination. Among FDA-approved adjuvants, aluminum salts are most commonly used in vaccines. Although aluminum salts enhance humoral immunity, they show a limited effect for cell-mediated immune responses. Thus, further…
read more here.
Keywords:
toll like;
molecule;
gold nanoparticles;
small molecule ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ACS chemical biology"
DOI: 10.1021/acschembio.2c00108
Abstract: Immunotherapy has become a powerful clinical strategy for treating infectious diseases and cancer. Synthetic small-molecule toll-like receptor 7 (TLR7) ligands are attractive candidates as immunostimulatory agents for immunotherapy. TLR7 is mainly localized in intracellular endosomal…
read more here.
Keywords:
small molecule;
tlr7 ligand;
tlr7;
1v209 man ... See more keywords